Covid-19: Seven Pharma Firms Reduce Price Of Remdesivir After Govt Intervention
The decision to reduce the price of the injection came days after the Centre held a meeting with all-existing manufacturers of Remdesivir. AP Outlook Web Bureau 2021-04-18T07:34:34+05:30 Covid-19: Seven Pharma Firms Reduce Price Of Remdesivir After Govt Intervention outlookindia.com 2021-04-18T07:50:07+05:30
Also read
In view of the shortage of Remdesivir, an antiviral considered important in the treatment of Covid-19, the manufacturers of the drug have slashed the price after the Indian government s request.
The reduction in the prices by Remdesivir producing companies is about 39% as demand for the drug shot up.
The Maharashtra government has decided to set up district-level control rooms to ensure smooth supply of Remdesivir injections and prevent hoarding and black-marketing of the drug, officials said on Sunday. Remdesivir is considered a key medicine in the fight against COVID-19, especially in adult patients with severe complications. The state is facing multiple issues pertaining to the drug, like demand-supply gap, its hoarding and black-marketing by stockists and pharmacy shops, unaffordable prices and irrational prescription by some doctors. Maharashtra s health services commissioner Ramaswami N, in a letter dated April 9, has written to all district collectors in the state to set up control rooms to streamline the supply of the key anti-viral drug.